BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22454481)

  • 21. Akt2 (Protein Kinase B Beta) Stabilizes ATP7A, a Copper Transporter for Extracellular Superoxide Dismutase, in Vascular Smooth Muscle: Novel Mechanism to Limit Endothelial Dysfunction in Type 2 Diabetes Mellitus.
    Sudhahar V; Okur MN; Bagi Z; O'Bryan JP; Hay N; Makino A; Patel VS; Phillips SA; Stepp D; Ushio-Fukai M; Fukai T
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):529-541. PubMed ID: 29301787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Losartan improves aortic endothelium-dependent relaxation via proline-rich tyrosine kinase 2/Src/Akt pathway in type 2 diabetic Goto-Kakizaki rats.
    Nemoto S; Kobayashi T; Taguchi K; Matsumoto T; Kamata K
    Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2383-94. PubMed ID: 21926342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poly(ADP-Ribose) polymerase inhibition improves erectile function in diabetic rats.
    Wan ZH; Li WZ; Li YZ; Chen L; Li GH; Hu WF; Peng S; Yu JJ; Guo F
    J Sex Med; 2011 Apr; 8(4):1002-14. PubMed ID: 20807334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Poly(ADP-ribose) polymerase inhibition improves endothelial dysfunction induced by reactive oxidant hydrogen peroxide in vitro.
    Radovits T; Lin LN; Zotkina J; Gero D; Szabó C; Karck M; Szabó G
    Eur J Pharmacol; 2007 Jun; 564(1-3):158-66. PubMed ID: 17397824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poly(ADP-ribose)polymerase 1 inhibition protects against age-dependent endothelial dysfunction.
    Zhang GH; Chao M; Hui LH; Xu DL; Cai WL; Zheng J; Gao M; Zhang MX; Wang J; Lu QH
    Clin Exp Pharmacol Physiol; 2015 Dec; 42(12):1266-74. PubMed ID: 26331430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poly(ADP-Ribose) polymerase inhibition improves endothelial dysfunction induced by hypochlorite.
    Radovits T; Zotkina J; Lin LN; Bömicke T; Arif R; Gerö D; Horváth EM; Karck M; Szabó C; Szabó G
    Exp Biol Med (Maywood); 2007 Oct; 232(9):1204-12. PubMed ID: 17895528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poly(ADP-ribose) polymerase inhibitors activate the p53 signaling pathway in neural stem/progenitor cells.
    Okuda A; Kurokawa S; Takehashi M; Maeda A; Fukuda K; Kubo Y; Nogusa H; Takatani-Nakase T; Okuda S; Ueda K; Tanaka S
    BMC Neurosci; 2017 Jan; 18(1):14. PubMed ID: 28095779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poly(ADP-ribose) polymerase contributes to the development of myocardial infarction in diabetic rats and regulates the nuclear translocation of apoptosis-inducing factor.
    Xiao CY; Chen M; Zsengellér Z; Szabó C
    J Pharmacol Exp Ther; 2004 Aug; 310(2):498-504. PubMed ID: 15054118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulation of autophagy improves vascular function in the mesenteric arteries of type 2 diabetic mice.
    Choi SK; Kwon Y; Byeon S; Lee YH
    Exp Physiol; 2020 Jan; 105(1):192-200. PubMed ID: 31736185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adiponectin abates diabetes-induced endothelial dysfunction by suppressing oxidative stress, adhesion molecules, and inflammation in type 2 diabetic mice.
    Lee S; Zhang H; Chen J; Dellsperger KC; Hill MA; Zhang C
    Am J Physiol Heart Circ Physiol; 2012 Jul; 303(1):H106-15. PubMed ID: 22561304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single dose treatment with PARP-inhibitor INO-1001 improves aging-associated cardiac and vascular dysfunction.
    Radovits T; Seres L; Gero D; Berger I; Szabó C; Karck M; Szabó G
    Exp Gerontol; 2007 Jul; 42(7):676-85. PubMed ID: 17383839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poly(ADP-Ribose) Polymerase Activity and Coronary Artery Disease in Type 2 Diabetes Mellitus: An Observational and Bidirectional Mendelian Randomization Study.
    Cui NH; Yang JM; Liu X; Wang XB
    Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2516-2526. PubMed ID: 32757651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic nitric oxide synthase inhibition blunts endothelium-dependent function of conduit coronary arteries, not arterioles.
    Ingram DG; Newcomer SC; Price EM; Eklund KE; McAllister RM; Laughlin MH
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2798-808. PubMed ID: 17259441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low molecular-weight fucoidan protects against hindlimb ischemic injury in type 2 diabetic mice through enhancing endothelial nitric oxide synthase phosphorylation.
    Liu T; Wang Z; Chen X; You H; Xue J; Cai D; Zheng Y; Xu Y; Luo D
    J Diabetes; 2018 Nov; 10(11):820-834. PubMed ID: 29633569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial nitric oxide synthase enhancer reduces oxidative stress and restores endothelial function in db/db mice.
    Cheang WS; Wong WT; Tian XY; Yang Q; Lee HK; He GW; Yao X; Huang Y
    Cardiovasc Res; 2011 Nov; 92(2):267-75. PubMed ID: 21875904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of PAR2 in regulating TNF-α and NAD(P)H oxidase in coronary arterioles in type 2 diabetic mice.
    Park Y; Yang J; Zhang H; Chen X; Zhang C
    Basic Res Cardiol; 2011 Jan; 106(1):111-23. PubMed ID: 20972877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice.
    Baumgardt SL; Paterson M; Leucker TM; Fang J; Zhang DX; Bosnjak ZJ; Warltier DC; Kersten JR; Ge ZD
    Circ Heart Fail; 2016 Jan; 9(1):e002424. PubMed ID: 26763290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poly(ADP-ribose) polymerase-1 (PARP-1) gene deficiency alleviates diabetic kidney disease.
    Shevalye H; Maksimchyk Y; Watcho P; Obrosova IG
    Biochim Biophys Acta; 2010 Nov; 1802(11):1020-7. PubMed ID: 20621183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of advanced glycation end products with oxidative stress in resistance artery dysfunction in type 2 diabetic mice.
    Su J; Lucchesi PA; Gonzalez-Villalobos RA; Palen DI; Rezk BM; Suzuki Y; Boulares HA; Matrougui K
    Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1432-8. PubMed ID: 18483403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The angiotensin receptor blocker losartan reduces coronary arteriole remodeling in type 2 diabetic mice.
    Husarek KE; Katz PS; Trask AJ; Galantowicz ML; Cismowski MJ; Lucchesi PA
    Vascul Pharmacol; 2016 Jan; 76():28-36. PubMed ID: 26133668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.